Lv1
58 积分 2024-05-27 加入
Dose Optimization of ClpP Agonists Using an In Vitro Microfluidic Perfusion Platform and In Silico Pharmacokinetic-Pharmacodynamic Modeling
1个月前
已完结
Exposure‐tumour growth inhibition modelling of brigimadlin using phase I solid tumour data to support phase II dose selection
1个月前
已完结
Controlled adsorption of multiple bioactive proteins enables targeted mast cell nanotherapy
2个月前
已完结
Early Life Adversity Programs Mast Cells Toward a Hyperactive Phenotype into Adulthood
2个月前
已关闭
Metabolic Stability Assessed by Liver Microsomes and Hepatocytes
3个月前
已完结
World Health Organization Classification and Diagnosis of Mastocytosis
4个月前
已完结
A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation
4个月前
已完结
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper
4个月前
已关闭
KIT D816V is dimerization‐independent and activates downstream pathways frequently perturbed in mastocytosis
4个月前
已完结
KIT Mutations and Other Genetic Defects in Mastocytosis
5个月前
已完结
皖公网安备34019202002308
